Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 37(2024), 2 vom: 08. März, Seite 183-185 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Monitorización farmacocinética de isavuconazol en un paciente con soporte de oxigenación por membrana extracorpórea |
---|
Beteiligte Personen: |
Herranz-Bayo, E [VerfasserIn] |
---|
Links: |
---|
Themen: |
60UTO373KE |
---|
Anmerkungen: |
Date Completed 08.03.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.37201/req/120.2023 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368220745 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368220745 | ||
003 | DE-627 | ||
005 | 20240320234143.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240209s2024 xx |||||o 00| ||spa c | ||
024 | 7 | |a 10.37201/req/120.2023 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM368220745 | ||
035 | |a (NLM)38332585 | ||
035 | |a (PII)herranz09feb2024 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Herranz-Bayo, E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacokinetic monitoring of isavuconazole in a patient with extracorporeal membrane oxygenation support |
246 | 3 | 3 | |a Monitorización farmacocinética de isavuconazol en un paciente con soporte de oxigenación por membrana extracorpórea |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.03.2024 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a case report | |
650 | 4 | |a extracorporeal membrane oxygenation | |
650 | 4 | |a isavuconazole | |
650 | 4 | |a pharmacokinetics | |
650 | 7 | |a isavuconazole |2 NLM | |
650 | 7 | |a 60UTO373KE |2 NLM | |
650 | 7 | |a Nitriles |2 NLM | |
650 | 7 | |a Pyridines |2 NLM | |
650 | 7 | |a Triazoles |2 NLM | |
700 | 1 | |a Huarte-Lacunza, R |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Chueca, P |e verfasserin |4 aut | |
700 | 1 | |a Aguiló-Lafarga, I |e verfasserin |4 aut | |
700 | 1 | |a Pinilla-Rello, A |e verfasserin |4 aut | |
700 | 1 | |a Sampedro-Calavia, E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia |d 1997 |g 37(2024), 2 vom: 08. März, Seite 183-185 |w (DE-627)NLM090649028 |x 1988-9518 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2024 |g number:2 |g day:08 |g month:03 |g pages:183-185 |
856 | 4 | 0 | |u http://dx.doi.org/10.37201/req/120.2023 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2024 |e 2 |b 08 |c 03 |h 183-185 |